Predicting Phospholipidosis Using Machine Learning

Molecular Pharmaceutics
2010.0

Abstract

Phospholipidosis is an adverse effect caused by numerous cationic amphiphilic drugs and can affect many cell types. It is characterized by the excess accumulation of phospholipids and is most reliably identified by electron microscopy of cells revealing the presence of lamellar inclusion bodies. The development of phospholipidosis can cause a delay in the drug development process, and the importance of computational approaches to the problem has been well documented. Previous work on predictive methods for phospholipidosis showed that state of the art machine learning methods produced the best results. Here we extend this work by looking at a larger data set mined from the literature. We find that circular fingerprints lead to better models than either E-Dragon descriptors or a combination of the two. We also observe very similar performance in general between Random Forest and Support Vector Machine models.

Knowledge Graph

Similar Paper

Predicting Phospholipidosis Using Machine Learning
Molecular Pharmaceutics 2010.0
Development of a Phospholipidosis Database and Predictive Quantitative Structure-Activity Relationship (QSAR) Models
Toxicology Mechanisms and Methods 2008.0
In Silico Assay for Assessing Phospholipidosis Potential of Small Druglike Molecules: Training, Validation, and Refinement Using Several Data Sets
Journal of Medicinal Chemistry 2012.0
Evaluation of a Published in Silico Model and Construction of a Novel Bayesian Model for Predicting Phospholipidosis Inducing Potential
Journal of Chemical Information and Modeling 2007.0
Prediction of acetylcholinesterase inhibitors and characterization of correlative molecular descriptors by machine learning methods
European Journal of Medicinal Chemistry 2010.0
A Predictive Ligand-Based Bayesian Model for Human Drug-Induced Liver Injury
Drug Metabolism and Disposition 2010.0
The conformation-dependent lipophilicity of morphine glucuronides as calculated from their molecular lipophilicity potential
Bioorganic & Medicinal Chemistry Letters 1994.0
In Silico Prediction of Volume of Distribution in Human Using Linear and Nonlinear Models on a 669 Compound Data Set
Journal of Medicinal Chemistry 2009.0
In silico prediction of novel phosphodiesterase type-5 inhibitors derived from Sildenafil, Vardenafil and Tadalafil
Bioorganic & Medicinal Chemistry 2008.0
Bisphosphonate Inhibition of aPlasmodiumFarnesyl Diphosphate Synthase and a General Method for Predicting Cell-Based Activity from Enzyme Data
Journal of Medicinal Chemistry 2008.0